Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Tibet Rhodiola Pharmaceutical Holding Co
Other Current Assets
Tibet Rhodiola Pharmaceutical Holding Co
Other Current Assets Peer Comparison
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
|
Other Current Assets
¥1.2B
|
CAGR 3-Years
360%
|
CAGR 5-Years
204%
|
CAGR 10-Years
46%
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Other Current Assets
¥29.4B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
15%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Other Current Assets
¥5.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
0%
|
CAGR 10-Years
18%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Other Current Assets
¥12.3B
|
CAGR 3-Years
58%
|
CAGR 5-Years
34%
|
CAGR 10-Years
20%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Other Current Assets
¥195.5m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
6%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Other Current Assets
¥750.8m
|
CAGR 3-Years
23%
|
CAGR 5-Years
3%
|
CAGR 10-Years
11%
|
See Also
What is Tibet Rhodiola Pharmaceutical Holding Co's Other Current Assets?
Other Current Assets
1.2B
CNY
Based on the financial report for Mar 31, 2024, Tibet Rhodiola Pharmaceutical Holding Co's Other Current Assets amounts to 1.2B CNY.
What is Tibet Rhodiola Pharmaceutical Holding Co's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
46%
Over the last year, the Other Current Assets growth was 2 737%. The average annual Other Current Assets growth rates for Tibet Rhodiola Pharmaceutical Holding Co have been 360% over the past three years , 204% over the past five years , and 46% over the past ten years .